Regulation of Glucose Homeostasis by the Kv1.3 Channel

Kv1.3 通道对血糖稳态的调节

基本信息

  • 批准号:
    7216323
  • 负责人:
  • 金额:
    $ 24.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Voltage-gated potassium (Kv) channels regulate cell membrane potential and control a variety of cellular processes. Kv1.3, a Shaker-related Kv channel is expressed in several tissues and believed to participate in cell volume regulation, apoptosis, T cell activation, and renal solute homeostasis. Channel activity is regulated, in a complex manner, by threonine and serine phosphorylation. Serotonin and insulin can both down-regulate the activity of the Kv1.3 channel. In the case of insulin, channel inhibition is observed in the olfactory bulb, and is mediated by phosphorylation of multiple threonine sites. To investigate the function of Kv1.3 in vivo, we carried out preliminary studies using Kv1.3 deficient mice (Kv1.3-/-) generated by gene targeting. Examination of these mice revealed that they weigh less and are more sensitive to the glucose-lowering action of insulin than control littermates. Furthermore, the phenotype observed in Kv1.3-/- mice was recapitulated by the pharmacological blockade of Kv1.3 in wild-type (wt) and diabetic mice, suggesting that Kv1.3's action on insulin sensitivity is independent of body weight. Moreover, inhibition of Kv1.3 channel activity in a skeletal muscle cell line (L6) significantly increased cell glucose uptake. Taken together, these data Kv1.3 strongly support the notion that Kv1.3 and its signaling pathway represent a novel component of the homeostatic mechanisms that regulate glucose metabolism. As such, we believe further investigation is warranted, from the standpoint of gaining a more detailed physiological understanding of the process and of uncovering potential targets for the development of drugs useful in the management of diabetes. While the effect of Kv1.3 on the regulation of body weight is of significant physiological and clinical interest, the current proposal is limited to studying its role in glucose homeostasis. The broad aims of the work are to elucidate the cellular and molecular mechanisms by which Kv1.3 modulates peripheral glucose metabolism and cause increased insulin sensitivity. In the context of our preliminary work, we propose to test if Kv1.3 modulate glucose uptake via an insulin-dependent pathway, and to examine the cellular mechanisms that mediate the action of Kv1.3 on glucose metabolism.
描述(由申请人提供):电压门控钾(Kv)通道调节细胞膜电位并控制多种细胞过程。Kv1.3是一种Shaker相关的Kv通道,在多种组织中表达,并被认为参与细胞体积调节、凋亡、T细胞活化和肾脏溶质稳态。通道活性以复杂的方式受苏氨酸和丝氨酸磷酸化的调节。5-羟色胺和胰岛素均能下调Kv1.3通道的活性。在胰岛素的情况下,在嗅球中观察到通道抑制,并且通过多个苏氨酸位点的磷酸化介导。为了研究Kv1.3在体内的功能,我们使用通过基因打靶产生的Kv1.3缺陷小鼠(Kv1.3-/-)进行了初步研究。对这些小鼠的检查显示,与对照组同窝出生的小鼠相比,它们的体重更轻,对胰岛素的降糖作用更敏感。此外,在Kv1.3-/-小鼠中观察到的表型被野生型(wt)和糖尿病小鼠中Kv1.3的药理学阻断所概括,表明Kv1.3对胰岛素敏感性的作用与体重无关。此外,在骨骼肌细胞系(L 6)中抑制Kv1.3通道活性显著增加细胞葡萄糖摄取。综上所述,这些数据Kv1.3强烈支持Kv1.3及其信号通路代表调节葡萄糖代谢的稳态机制的新组分的概念。 因此,我们认为,从获得对该过程更详细的生理学理解和发现用于开发糖尿病管理药物的潜在靶点的角度来看,有必要进行进一步的研究。 虽然Kv1.3对体重调节的作用具有重要的生理和临床意义,但目前的建议仅限于研究其在葡萄糖稳态中的作用。 这项工作的主要目的是阐明Kv1.3调节外周葡萄糖代谢和引起胰岛素敏感性增加的细胞和分子机制。 在我们的初步工作的背景下,我们建议测试,如果Kv1.3通过胰岛素依赖性途径调节葡萄糖摄取,并检查介导Kv1.3对葡萄糖代谢的作用的细胞机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary V. Desir其他文献

Immunocytochemical characterization of the high-affinity thiazide diuretic receptor in rabbit renal cortex.
兔肾皮质高亲和力噻嗪类利尿受体的免疫细胞化学表征。
  • DOI:
  • 发表时间:
    1993
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David H. Ellison;D. Biemesderfer;J. Morrisey;J. Lauring;Gary V. Desir
  • 通讯作者:
    Gary V. Desir
Solubilization and partial purification of the thiazide diuretic receptor from rabbit renal cortex.
兔肾皮质噻嗪利尿受体的溶解和部分纯化。
  • DOI:
    10.1016/0005-2736(91)90131-q
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David H. Ellison;James Morrisey;Gary V. Desir
  • 通讯作者:
    Gary V. Desir
Regulation of the voltage-gated K+ channel KCNA10 by KCNA4B, a novel β-subunit
KCNA4B(一种新型 β 亚基)对电压门控 K+ 通道 KCNA10 的调节
  • DOI:
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. Tian;Weimin Liu;Yanling Wu;H. Rafi;Alan S. Segal;Gary V. Desir
  • 通讯作者:
    Gary V. Desir
Rabbit distal convoluted tubule coexpresses NaCl cotransporter and 11β-hydroxysteroid dehydrogenase II mRNA
  • DOI:
    10.1046/j.1523-1755.1998.00036.x
  • 发表时间:
    1998-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Heino Velázquez;Aniko Náray-Fejes-Tóth;Teresa Silva;Eleanor Andújar;Robert F. Reilly;Gary V. Desir;David H. Ellison
  • 通讯作者:
    David H. Ellison

Gary V. Desir的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary V. Desir', 18)}}的其他基金

Renalase inhibition for treatment of unresectable melanoma
肾酶抑制治疗不可切除的黑色素瘤
  • 批准号:
    9902357
  • 财政年份:
    2017
  • 资助金额:
    $ 24.48万
  • 项目类别:
Renalase inhibition for treatment of unresectable melanoma
肾酶抑制治疗不可切除的黑色素瘤
  • 批准号:
    9319928
  • 财政年份:
    2017
  • 资助金额:
    $ 24.48万
  • 项目类别:
Therapeutic Utility of renalase and renalase peptides in cisplatin-mediated renal
肾酶和肾酶肽在顺铂介导的肾病中的治疗用途
  • 批准号:
    8781124
  • 财政年份:
    2014
  • 资助金额:
    $ 24.48万
  • 项目类别:
RENALASE DEFICIENCY AND CARDIOVASCULAR COMPLICATIONS OF CHRONIC KIDNEY DISEASE
慢性肾病的肾酶缺乏和心血管并发症
  • 批准号:
    7820757
  • 财政年份:
    2010
  • 资助金额:
    $ 24.48万
  • 项目类别:
RENALASE IN ACUTE KIDNEY INJURY: UTILITY AS A BIOMARKER, AND THERAPEUTIC AGENT
急性肾损伤中的肾酶:作为生物标志物和治疗剂的实用性
  • 批准号:
    7820609
  • 财政年份:
    2010
  • 资助金额:
    $ 24.48万
  • 项目类别:
The Molecular Physiology of Renalase
肾酶的分子生理学
  • 批准号:
    7730916
  • 财政年份:
    2009
  • 资助金额:
    $ 24.48万
  • 项目类别:
The Molecular Physiology of Renalase
肾酶的分子生理学
  • 批准号:
    7917422
  • 财政年份:
    2009
  • 资助金额:
    $ 24.48万
  • 项目类别:
Regulation of Glucose Homeostasis by the Kv1.3 Channel
Kv1.3 通道对血糖稳态的调节
  • 批准号:
    7034665
  • 财政年份:
    2004
  • 资助金额:
    $ 24.48万
  • 项目类别:
Regulation of Glucose Homeostasis by the Kv1.3 Channel
Kv1.3 通道对血糖稳态的调节
  • 批准号:
    6780490
  • 财政年份:
    2004
  • 资助金额:
    $ 24.48万
  • 项目类别:
Regulation of Glucose Homeostasis by the Kv1.3 Channel
Kv1.3 通道对血糖稳态的调节
  • 批准号:
    7391194
  • 财政年份:
    2004
  • 资助金额:
    $ 24.48万
  • 项目类别:

相似海外基金

Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
  • 批准号:
    MR/Y013891/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.48万
  • 项目类别:
    Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
  • 批准号:
    BB/Y006542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.48万
  • 项目类别:
    Research Grant
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
  • 批准号:
    23H03323
  • 财政年份:
    2023
  • 资助金额:
    $ 24.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
  • 批准号:
    23K08293
  • 财政年份:
    2023
  • 资助金额:
    $ 24.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
  • 批准号:
    479570
  • 财政年份:
    2023
  • 资助金额:
    $ 24.48万
  • 项目类别:
    Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
  • 批准号:
    488898
  • 财政年份:
    2023
  • 资助金额:
    $ 24.48万
  • 项目类别:
    Operating Grants
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
  • 批准号:
    23K19922
  • 财政年份:
    2023
  • 资助金额:
    $ 24.48万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
  • 批准号:
    10605981
  • 财政年份:
    2023
  • 资助金额:
    $ 24.48万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 24.48万
  • 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
  • 批准号:
    10604611
  • 财政年份:
    2023
  • 资助金额:
    $ 24.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了